Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue.
Lapidari P, Djehal N, Havas J, Gbenou A, Martin E, Charles C, Dauchy S, Pistilli B, Cadeau C, Bertaut A, Everhard S, Martin AL, Coutant C, Cottu P, Menvielle G, Dumas A, Andre F, Michiels S, Vaz-Luis I, Di Meglio A. Lapidari P, et al. Breast Cancer Res Treat. 2021 Dec;190(3):517-529. doi: 10.1007/s10549-021-06394-2. Epub 2021 Sep 24. Breast Cancer Res Treat. 2021. PMID: 34559354
Factors associated with enrolment in clinical trials among women with early-stage breast cancer.
Presti D, Havas J, Soldato D, Lapidari P, Martin E, Pistilli B, Jouannaud C, Emile G, Rigal O, Fournier M, Soulie P, Mouret-Reynier MA, Tarpin C, Campone M, Guillermet S, Martin AL, Everhard S, Di Meglio A. Presti D, et al. Among authors: lapidari p. ESMO Open. 2022 Jun;7(3):100513. doi: 10.1016/j.esmoop.2022.100513. Epub 2022 Jun 17. ESMO Open. 2022. PMID: 35724624 Free PMC article.
Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer.
Lapidari P, Gbenou A, Havas J, Martin E, Pistilli B, Martin AL, Everhard S, Coutant C, Cottu P, Lesur A, Lerebours F, Tredan O, Vanlemmens L, Jouannaud C, Levy C, Rigal O, Fournier M, Andre F, Vaz-Luis I, Di Meglio A. Lapidari P, et al. Breast. 2021 Jun;57:43-48. doi: 10.1016/j.breast.2021.02.014. Epub 2021 Mar 2. Breast. 2021. PMID: 33711699 Free PMC article.
Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis.
Vaz-Luis I, Di Meglio A, Havas J, El-Mouhebb M, Lapidari P, Presti D, Soldato D, Pistilli B, Dumas A, Menvielle G, Charles C, Everhard S, Martin AL, Cottu PH, Lerebours F, Coutant C, Dauchy S, Delaloge S, Lin NU, Ganz PA, Partridge AH, André F, Michiels S. Vaz-Luis I, et al. Among authors: lapidari p. J Clin Oncol. 2022 Jul 1;40(19):2148-2162. doi: 10.1200/JCO.21.01958. Epub 2022 Mar 15. J Clin Oncol. 2022. PMID: 35290073 Free PMC article.
Coffee and tea consumption, patient-reported, and clinical outcomes in a longitudinal study of patients with breast cancer.
Soldato D, Havas J, Crane TE, Presti D, Lapidari P, Rassy N, Pistilli B, Martin E, Del Mastro L, Martin AL, Jacquet A, Coutant C, Cottu P, Merimeche A, Lerebours F, Tredan O, Vanlemmens L, André F, Vaz-Luis I, Di Meglio A. Soldato D, et al. Among authors: lapidari p. Cancer. 2022 Oct 1;128(19):3552-3563. doi: 10.1002/cncr.34401. Epub 2022 Aug 1. Cancer. 2022. PMID: 35913436 Free PMC article.
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience.
Palumbo R, Sottotetti F, Quaquarini E, Gambaro A, Ferzi A, Tagliaferri B, Teragni C, Licata L, Serra F, Lapidari P, Bernardo A. Palumbo R, et al. Among authors: lapidari p. Ther Adv Med Oncol. 2019 Jun 4;11:1758835919833864. doi: 10.1177/1758835919833864. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31210797 Free PMC article.
Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR+/HER2- metastatic breast cancer: a prospective, monocentric study.
Palumbo R, Quaquarini E, Saltalamacchia G, Malovini A, Lapidari P, Tagliaferri B, Mollica L, Teragni CM, Barletta C, Locati LD, Sottotetti F. Palumbo R, et al. Among authors: lapidari p. Drugs Context. 2024 Feb 5;13:2023-7-5. doi: 10.7573/dic.2023-7-5. eCollection 2024. Drugs Context. 2024. PMID: 38332945 Free PMC article.
Telehealth in breast cancer following the coronavirus disease 2019 pandemic.
Zeghondy J, Rassy E, Lapidari P, Eid R, Pistilli B. Zeghondy J, et al. Among authors: lapidari p. Explor Target Antitumor Ther. 2023;4(6):1249-1259. doi: 10.37349/etat.2023.00195. Epub 2023 Dec 26. Explor Target Antitumor Ther. 2023. PMID: 38213534 Free PMC article. Review.
12 results